A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes

Boehringer Ingelheim

Status: Completed

Conditions: Diabetes Mellitus, Type 2

Treatments: Drug: TRADIANCE® Combination Tablets BP; Drug: TRADIANCE® Combination Tablets AP

Study type: Observational

Funder types: Industry

Identifiers

NCT03761797

1275-0026

Details and patient eligibility

About

Study objectives is to investigate the safety of long-term daily use of TRADIANCE® Combination Tablets AP and BP in Japanese patients with Type 2 Diabetes mellitus (T2DM) used in routine care.

Enrollment: 1,164 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Japanese patients with Type 2 Diabetes mellitus (T2DM) who are prescribed with TRADIANCE® Combination Tablets AP or BP
• Patients who have never been treated with TRADIANCE® Combination Tablets AP or BP before enrolment

Exclusion criteria

None

Trial design

1,164 participants in 1 patient group

Subjects with type 2 Diabetes Mellitus

Treatment:

Drug: TRADIANCE® Combination Tablets AP

Drug: TRADIANCE® Combination Tablets BP